Blood Genome-Wide Transcriptional Profiles of HER2 Negative Breast Cancers Patients

<div>Venn diagram of genes/sequences with differential expression exceeding 1.5-fold in the compared groups. The overlap areas show unique signatures for ER+PR+HER2− (108) and ER−PR−HER2− (TNBC) (34) subtypes.</div>

Mediators of Inflammation

fig2

Figure 2

Figure 2: Blood Genome-Wide Transcriptional Profiles of HER2 Negative Breast Cancers Patients 